Therapeutic Effects of Human Amniotic Fluid-Derived Stem Cells on Renal Interstitial Fibrosis in a Murine Model of Unilateral Ureteral Obstruction

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Sun, Dong ^a,b   Bu, Lin ^a   Liu, Caixia ^a   Yin, Zhongcheng ^a   Zhou, Xudong ^b   Li, Xiaoju ^b   Xiao, Aiguo ^b  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b Kuitun Hospital of Ili Kazakh Autonomous Prefecture   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VASCULOTROPIN; WT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL PARAMETERS; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN AMNIOTIC FLUID DERIVED STEM CELL TRANSPLANTATION; KIDNEY BIOPSY; KIDNEY FIBROSIS; MICROVASCULAR DENSITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RENAL PROTECTION; STEM CELL TRANSPLANTATION; URETER OBSTRUCTION;

AMNIOTIC FLUID; ANIMALS; APOPTOSIS; CADHERINS; CAPILLARIES; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; CHEMOKINE CCL2; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; FIBROSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IN SITU NICK-END LABELING; KI-67 ANTIGEN; KIDNEY DISEASES; KIDNEY TUBULES; MICE; PHENOTYPE; PROLIFERATING CELL NUCLEAR ANTIGEN; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE;

EID: 84878409360     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065042     Document Type: Article

References (52)

1. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, et al. (2004) Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality:a pooled analysis of community-based studies. J Am Soc Nephrol 15(5): 1307-1315.
2. Chiurchiu C, Remuzzi G, Ruggenenti P, (2005) Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: the data of the meta-analyses. J Am Soc Nephrol 16: s58-63.
3. Flaquer M, Romagnani P, Cruzado JM, (2010) Growth factors and renal regeneration. Nefrologia 30(4): 385-393.
4. Kunter U, Rong S, Djuric Z, Boor P, Muller-Newen G, et al. (2006) Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 17(8): 2202-2212.
5. Lange C, Togel F, Ittrich H, Clayton F, Nolte-Ernsting C, et al. (2005) Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int 68(4): 1613-1617.
6. Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG, (2007) Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18(9): 2486-2496.
7. Hopkins C, Li J, Rae F, Little MH, (2009) Stem cell options for kidney disease. J Pathol 217(2): 265-281.
8. Fang TC, Otto WR, Rao J, Jeffery R, Hunt T, et al. (2008) Haematopoietic lineage-committed bone marrow cells, but not cloned cultured mesenchymal stem cells, contribute to regeneration of renal tubular epithelium after HgCL2-induced acute tubular injury. Cell Prolif 41(4): 575-591.
9. Humphreys BD, Bonventre JV, (2008) Mesenchymal Stem cells in Acute Kidney Injury. Annu Rev Med 59: 311-325.
10. Lin F, Cordes K, Li L, Hood L, Couser WG, et al. (2003) Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 14(5): 1188-1199.
11. Broekema M, Harmsen MC, Koerts JA, Petersen AH, Van Luyn MJ, et al. (2005) Determinants of tubular bone marrow-derived cell engraftment after renal ischemia/reperfusion in rats. Kidney Int 68(6): 2572-2581.
12. Phermthai T, Odglun Y, Julavijitphong S, Titapant V, Chuenwattana P, et al. (2010) A novel method to derive amniotic fluid stem cells for therapeutic purposes. BMC Cell Biol 11: 79.
13. Perin L, Giuliani S, Jin D, Sedrakyan S, Carraro G, et al. (2007) Renal differentiation of amniotic fluid stem cells. Cell Prolif 40(6): 936-948.
14. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, et al. (2004) Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta. Stem Cells 22(7): 1338-1345.
15. Lin F, Moran A, Igarashi P, (2005) Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 115(7): 1756-1764.
16. Flaquer M, Romagnani P, Cruzado JM, (2010) Growth factors and renal regeneration. Nefrologia 30(4): 385-393.
17. Prusa A-R, Marton E, Rosner M, Bernaschek G, Hengstschlager M, (2003) Oct-4-expressing cells in human amniotic fluid: a new source for stem cell reseach? Human Reprod 18(7): 1489-1493.
18. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, et al. (2007) Isolation of amniotic fluid stem cells lines with potential for therapy. Nature Biotechnology 25(1): 100-106.
19. Carraro G, Perin L, Sedrakyan S, Giuliani S, Tiozzo C, et al. (2008) Human Amniotic Fluid Stem Cells Can Integrate and Differentiate into Epithelial Lung Lineages. Stem Cells 26(11): 2902-2911.
20. Peister A, Deutsch ER, Kolambkar Y, Hutmacher DW, Guldberg RE, (2009) Amniotic Fluid Stem Cells Produce Robust Mineral Deposits on Biodegradable Scaffolds. Tissue Eng Part A 15(10): 3129-3138.
21. Perin L, Sedrakyan S, Giuliani S, Da Sacco S, Carraro G, et al. (2010) Protective Effect of Human Amniotic Fluid Stem Cells in an Immunodeficient Mouse Model of Acute Tubular Necrosis. PLoS One 5(2):e 9357.
22. Hauser PV, De Fazio R, Bruno S, Sdei S, Grange C, et al. (2010) Stem Cells Derived from Human Amniotic Fluid Contribute to Acute Kidney Injury Recovery. American Journal of Pathology 177(4): 2011-2021.
23. Ma YY, Sun D, Li J, Yin ZC, (2010) Transplantation of endothelial progenitor cells alleviates renal interstitial fibrosis in a mouse model of unilateral ureteral obstruction. Life Sci 86(21-22): 798-807.
24. Klahr S, Morrissey J, (2002) Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283(5): F861-875.
25. Schiffrin EL, Lipman ML, Mann JF, (2007) Chronic Kidney Disease: Effect on the Cardiovascular System. Circulation 116(1): 85-97.
26. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W, (2003) Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: The ARIC study. Kidney International 64(2): 610-615.
27. Duffield JS, Park KM, Hsiao LL, Kelley VR, Scadden DT, et al. (2005) Restoration of tubular epithelial cells during repair of the postischemic Kidney occurs independently of bone marrow-derived stem cells. J. Clin.Invest 115(7): 1743-1755.
28. Duffield JS, Bonventre JV, (2005) Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int 68(5): 1956-1961.
29. Togel F, Hu Z, Weiss K, Isaac J, Lange C, et al. (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289(1):F 31-42.
30. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, et al. (2009) Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury. J Am Soc Nephrol 20(5): 1053-1067.
31. Bussolati B, Hauser PV, Carvalhosa R, Camussi G, (2009) Contribution of Stem Cells to Kidney Repair. Curr Stem Cell ResTher 4(1): 2-8.
32. Brodie JC, Humes HD, (2005) Stem Cell Approaches for the Treatment of Renal Failure. Pharmacol Rev 57(3): 299-313.
33. Tsai MS, Lee JL, Chang YJ, Hwang SM, (2004) Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Human Reproduction 19(6): 1450-1456.
34. Choi YJ, Chakraborty S, Nguyen V, Nguyen C, Kim BK, et al. (2000) Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney:altered expression of vacular enthelial growth factor. Human Pathology 31(12): 1491-1497.
35. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, et al. (2001) Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol12(7): 1434-1447.
36. Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ, (2001) Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12(7): 1448-1457.
37. Zhang G, Ichimura T, Maier JA, Maciag T, Stevens JL, (1993) A role for fibroblast growth factor type-1 in nephrogenic repair. Autocrine expression in rat kidney proximal tubule epithelial cells in vitro and in the regenerating epithelium following nephrotoxic damage by S-(1,1,2,2,-tetrafluoroethy)-L-cysteine in vivo. J Biol Chem 268(16): 11542-7.
38. Nigam S, Lieberthal W, (2000) Acute renal failure. III. The role of growth factors in the process of renal regeneration and repair. Am J Physiol Renal Physiol 279(1): F3-F11.
39. Zhang B, Liang X, Shi W, Ye Z, He C, et al. (2005) Role of impaired peritubular capillary and hypoxia in progressive interstitial fibrosis after 56 subtotal nephrectomy of rats. Nephrology(Carlton) 10(4): 351-357.
40. Orphanides C, Fine LG, Norman JT, (1997) Hypoxia stimulates proximal tubular cell matrix production via a TGF-betal-independent mechanism. Kidney Int 52(3): 637-647.
41. Manotham K, Tanaka T, Matsumoto M, Ohse T, Miyata T, et al. (2004) Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol 15(5): 1277-1288.
42. Stravodimos KG, Koritsiadis G, Lazaris AC, Agrogiannis G, Koutalellis G, et al. (2009) Hydronephrosis promotes expression of hypoxia inducible factor 1 alpha. Urologia Internationalis 82(1): 38-42.
43. Taipale J, Saharinen J, Hedman K, Keski-Oja J, (1996) Latent transforming growth factor-beta1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem 44(8): 875-889.
44. Various authors (1989) Immunodeficient Rodents: A Guide to Their Immunobiology, Husbandry, and Use. Committee on Immunologically Compromised Rodents, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council.
45. Wang M, Liu R, Jia X, Mu S, Xie R, (2010) N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal inflammation and tubulointerstitial fibrosis in rats. International Journal of Molecular Medicine 26(6): 795-801.
46. Gumbiner BM, (2005) Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Bio 6(8): 622-634.
47. Hewitson TD, Ho WY, Samuel CS, (2010) Antifibrotic Properties of Relaxin: In Vivo Mechanism of Action in Experimental Renal Tubulointerstitial Fibrosis. Renal Cardiac Vascular 151(10): 4938-4948.
48. Humphreys BD, Valerius MT, Kobayashi A, Mugford JW, Soeung S, et al. (2008) Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2(3): 284-291.
49. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, et al. (2009) Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20(5): 1053-1067.
50. Moriyama T, Kawada N, Ando A, Yamauchi A, Horio M, et al. (1998) Up-regulation of HSP47 in the mouse kidneys with unilateral ureteral obstruction. Kidney International 54(1): 110-119.
51. Djudjaj S, Chatziantoniou C, Raffetseder U, Guerrot D, Dussaule JC, et al. (2012) Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury. J Pathol doi: 10.1002/path.4076.
52. Sun D, Feng JM, Dai C, Sun L, Jin T, et al. (2006) Role of peritubular capillary loss and hypoxia in progressive tubulointerstitial fibrosis in a rat model of aristolochic acid nephropathy. American Journal of Nephrology 26(4): 363-371.